Clinical Trials Directory

Trials / Completed

CompletedNCT01973075

Genetic Etiology in Premature Ovarian Insufficiency

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
BEGUM AYDOGAN · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Premature Ovarian Insufficiency (POI), first described by Albright in 1942, is defined as an increase in Follicle Stimulating Hormone (FSH), an insufficiency of the ovarian function leading to an early menopause (\<40 years of age).Today, only 35% of POI's etiology can be explained. Causes enlightening POI may be enumerated as follows, according to their frequency: genetic mutations, autoimmune defects and abnormalities detected on the X chromosome.The purpose of the study is to determine the frequency of the genetic abnormalities and polymorphisms described above in the POI Turkish population

Conditions

Timeline

Start date
2013-11-01
Primary completion
2016-04-01
Completion
2017-04-01
First posted
2013-10-31
Last updated
2017-08-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01973075. Inclusion in this directory is not an endorsement.

Genetic Etiology in Premature Ovarian Insufficiency (NCT01973075) · Clinical Trials Directory